A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Ac Immune Sa stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 3,577 shares of ACIU stock, worth $11,696. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,577
Previous 2,953 21.13%
Holding current value
$11,696
Previous $11,000 18.18%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$2.99 - $4.2 $1,865 - $2,620
624 Added 21.13%
3,577 $13,000
Q2 2024

Jul 30, 2024

BUY
$2.29 - $4.87 $6,762 - $14,381
2,953 New
2,953 $11,000
Q2 2021

Aug 11, 2021

BUY
$6.04 - $8.37 $7,133 - $9,884
1,181 New
1,181 $9,000

Others Institutions Holding ACIU

About AC Immune SA


  • Ticker ACIU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,413,504
  • Market Cap $273M
  • Description
  • AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...
More about ACIU
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.